期刊文献+

心脏植入式电子装置的远程随访与监测 被引量:2

下载PDF
导出
摘要 心脏植入式电子装置,包括起搏器植入式心脏除颤器(ICD)、心脏再同步治疗除颤器(CRT-D)和心脏再同步治疗起搏器(CRT-P)术后,患者需要长期随访。以往,医生只能在程控仪上获得这些数据,不但工作负荷日趋加重,而且患者复查成本较高,会导致失访率增加而带来安全隐患。近年来,随着无线发射技术的成熟和网络技术的普及应用,远程随访和监测成为新一代器械植入术后患者新的管理模式,正逐步得到推广。国外已积累了一些经验,我国正处于起步阶段。
出处 《中国介入心脏病学杂志》 2012年第5期291-293,共3页 Chinese Journal of Interventional Cardiology
  • 相关文献

参考文献19

  • 1Furman S, Parker B, Escher DJ. Trans-telephone pacemakerclinic. J Thorac Cardiovasc Surg, 1971,61:827-834.
  • 2Crossley GH, Chen J, Choucair W, et al. Clinical benefits ofremote versus transtelephonic monitoring of implantedpacemakers. J Am Coll Cardiol, 2009,54:2012-2019.
  • 3Kusumoto F,Goldschlager N. Remote monitoring of patients withimplanted cardiac devices. Clin Cardiol, 2010,33 : 10-17.
  • 4Varma N, Epstein AE, Irimpen A, et al. Efficacy and safety ofautomatic remote monitoring for implantable cardioverter-defibrillator follow-up : the Lumos-T Safely Reduces RoutineOffice Device Follow-up (TRUST) Trial. Circulation, 2010,122;325-332.
  • 5Spencker S, Coban N, Koch L, et al. Potential role of homemonitoring to reduce inappropriate shocks in implantablecardioverter-defibrillator patients due to lead failure. Europace,2009,11:409411.
  • 6Ricci RP, Morichelli L, Santini M. Home monitoringTMtechnology improves detection and clinical management of atrialfibrillation, Europace,2009,11 : 54-61.
  • 7Crossley GH, Boyle A, Vitense H, et al. The CONNECT(Clinical Evaluation of Remote Notification to Reduce Time toClinical Decision) trial: The value of wireless remote monitoringwith automatic clinician alerts. J Am Coll Cardiol, 2011,57:1181-1189.
  • 8Glotzer TV,Hellkamp AS, Zimmerman J, et al. Atrial high rateepisodes detected by pacemaker diagnostics predict death andstroke : report of the Atrial Diagnostics Ancillary Study of theMOde Selection Trial (MOST). Circulation, 2003 ,107 : 1614-1619.
  • 9Glotzer TV, Daoud EG,Wyse DG, et al. The relationshipbetween daily atrial tachyarrhythmia burden from implantabledevice diagnostics and stroke risk: The TRENDS study. CircArrhythm Electrophysiol, 2009,2:474-480.
  • 10Ip J, Waldo AL, Lip GY, et al. Multicenter randomized study ofanticoagulation guided by remote rhythm monitoring in patientswith implantable cardioverter-defibrillator and CRT-D devices :Rationale, design, and clinical characteristics of the initiallyenrolled cohort (The IMPACT study) . Am Heart J, 2009,158:364-370. e1.

同被引文献38

  • 1Mirowski M, Reid PR, Mower MM, et al. Termination of MalignantVentricular Arrhythmias with an Implanted Automatic Defibrillatorin Human Beings. N Engl J Med, 1980,303:322-324.
  • 2Curtis JP, Luebbert JJ, Wang Y, et al. Association of physiciancertification and outcomes among patients receiving an implantablecardioverter-defibrillator. JAMA, 2009, 301:1661-1670.
  • 3Kleemann T, Becker T, Doenges K, et al. Annual rate of transvenousdefibrillation lead defects in implantable cardioverter-defibrillatorsover a period of >10 years. Circulation, 2007, 115:2474-2480.
  • 4Bardy GH, Smith WM, Hood MA, et al. An Entirely SubcutaneousImplantable Cardioverter-Defibrillator. N Engl J Med, 2010,363:36-44.
  • 5Dabiri AL, Theuns DA, Valk SD, et al. Clinical experience witha novel subcutaneous implantable defibrillator system in a singlecenter. Clin Res Cardiol, 2011, 100:737-744.
  • 6Aydin A, Hartel F, Schluter M, et al. Shock efficacy of subcutaneousimplantable cardioverter-defibrillator for prevention of suddencardiac death: initial multicenter experience. Circ ArrhythmElectrophysiol, 2012, 5:913-919.
  • 7Olde Nordkamp LR, Dabiri Abkenari L, Boersma LV, et al. Theentirely subcutaneous implantable cardioverter-defibrillator: initialclinical experience in a large Dutch cohort. J Am Coll Cardiol, 2012,60:1933-1939.
  • 8Kobe J, Reinke F, Meyer C, et al. Implantation and follow-up oftotally subcutaneous versus conventional implantable cardioverter-defibrillators: a multicenter case-control study. Heart Rhythm, 2013,10:29-36.
  • 9Jarman JW, Todd DM. United Kingdom national experienceof entirely subcutaneous implantable cardioverter-defibrillatortechnology: important lessons to learn. Europace, 2013, 15:1158-1165.
  • 10Weiss R,Knight BP, Gold MR, et al. Safety and efficacy of a totallysubcutaneous implantable-cardioverter defibrillator. Circulation,2013,128:944-953.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部